COVID-19 and the liver: What do we know after six months of the pandemic?

Despite liver injury in patients infected with severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver dysfunction is mainly described in patients with severe viral disease. How liver abnormalities may affect virus infection i...

Full description

Saved in:
Bibliographic Details
Published inAnnals of hepatology Vol. 19; no. 6; pp. 590 - 591
Main Author Fierro, Nora A.
Format Journal Article
LanguageEnglish
Published Mexico Elsevier España, S.L.U 01.11.2020
Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U
Elsevier
Subjects
Betacoronavirus
Coronavirus Infections - complications
Coronavirus Infections - diagnosis
Coronavirus Infections - therapy
COVID-19
COVID-19 comorbidities
COVID-19 symptoms
Humans
Liver disease
Liver Diseases - diagnosis
Liver Diseases - therapy
Liver Diseases - virology
Opinions
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - diagnosis
Pneumonia, Viral - therapy
SARS
SARS-CoV-2
SARS
COVID-19 comorbidities
COVID-19 symptoms
Liver disease
Online AccessGet full text

Cover

More Information
Summary:Despite liver injury in patients infected with severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver dysfunction is mainly described in patients with severe viral disease. How liver abnormalities may affect virus infection is still unknown. Improved understanding of host genetics, lifestyle, underlying comorbidities and adequate follow-up of patients with liver damage are critical in the new scenario of the pandemic virus.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1665-2681
2659-5982
1665-2681
DOI:10.1016/j.aohep.2020.09.001